The U.S. general public has low knowledge and confidence about mindfulness-based stress reduction (MBSR) for chronic pain, but holds positive general beliefs about MBSR. Beliefs about pharmacy-delivered MBSR were more negative. Confidence in seeking MBSR and current opioid use were positively associated with beliefs about pharmacy-delivered MBSR, while higher income and greater bodily pain were negatively associated. Most respondents preferred a hybrid class format combining online and in-person sessions, and both group and individual options. Further education is needed to improve public perception of community pharmacies as a resource for complementary and integrative health.
Lysergic acid amide (LSA), consumed mainly from Convolvulaceae plant seeds, produces euphoria, hallucinations, nausea, and anxiety. Severe adverse outcomes include psychosis, hypertension, and hospitalization. Some evidence suggests potential therapeutic application for cluster headaches, but variability in dosing and online misinformation heighten risks. The systematic review of 17 human studies concludes that LSA poses significant health risks, exacerbated by a lack of scientific studies, and calls for further research to clarify its pharmacological profile and establish safety guidelines.